Physician profile
Grace Levine
NPI 1457887572
$2,334.86
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.03 · 2020: $55.25 · 2021: $725 · 2022: $781 · 2023: $668 · 2024: $69.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $737.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $736.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $588.48 | 2020-2024 | |
| Aspira Women'S Health INC | $255.23 | 2021 | |
| Therapeuticsmd, INC. | $247.00 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $180.39 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $133.44 | 2022-2023 | |
| Evofem Biosciences, INC. | $125.09 | 2021-2022 | |
| Myovant Sciences INC. | $107.78 | 2021-2022 | |
| Pfizer INC. | $74.93 | 2022-2023 | |
| Exeltis, USA INC. | $70.06 | 2022-2023 | Slynd |
| Coopersurgical, INC. | $59.39 | 2021-2023 | Paragard T 380a |
| Mylan Pharmaceuticals INC. | $57.95 | 2021-2022 | |
| Renovia INC | $41.77 | 2021 | |
| Amgen INC. | $40.40 | 2021 | |
| Dysis Medical, INC. | $39.68 | 2022 | |
| Sumitomo Pharma America, INC. | $38.06 | 2023-2024 | Myfembree |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $32.76 | 2023 | Arista Ah Flexitip |
| Urovant Sciences INC | $31.53 | 2022 | |
| Hologic Sales and Service, LLC | $29.66 | 2024 | Aptima |
| Radius Health, INC. | $25.32 | 2023 | Tymlos |
| Avion Pharmaceuticals | $22.79 | 2023 | Balcoltra |
| Exact Sciences Corporation | $22.33 | 2023 | Cologuard Collection Kit |
| Roche Diagnostics Corporation | $18.86 | 2019 | |
| Scynexis, INC. | $18.24 | 2022 | |
| Alexion Pharmaceuticals, INC. | $18.17 | 2019 | |
| Covidien Lp | $16.73 | 2020 | |
| Organon LLC | $14.20 | 2021 | |
| Merck Sharp & Dohme LLC | $14.07 | 2023 | Belsomra |
| Meditrina | $10.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Levine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.